Plain-English translation of NCT06971848 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Biotherapy medications like Atezolizumab, Nivolumab, and Pembrolizumab are important treatments for cancer and blood disorders, but some patients experience allergic reactions to them. Right now, doctors don't have clear guidelines on how to safely test patients' skin to check for these allergies before treatment. This study will establish the right way to perform these skin tests.
Unlike allergy testing for antibiotics and other drugs, there are no official standards for testing allergic reactions to these cancer medications. This trial will create evidence-based guidelines so doctors can safely and reliably detect allergies before patients receive the medication.
You likely qualify if…
You likely don't qualify if…
You will visit the study center to undergo skin tests, which involve applying small amounts of the medication to your skin to see if you have an allergic reaction. The researchers will observe and document any reactions. The visit should take a few hours, and you'll need to avoid certain medications (like antihistamines and steroids) for about a week before coming in. This is a one-time testing procedure, not an ongoing treatment study.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
France